SBF 120
6.092,63
PKT
-48,45
PKT
-0,79
%
Werbung
Analysen zu SBF 120-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.03.21 | SAFRAN Neutral | Credit Suisse Group | |
| 02.03.21 | Danone Underperform | Bernstein Research | |
| 02.03.21 | Sanofi Sell | Deutsche Bank AG | |
| 02.03.21 | Airbus Hold | Jefferies & Company Inc. | |
| 02.03.21 | Danone buy | Jefferies & Company Inc. | |
| 02.03.21 | Danone Neutral | Goldman Sachs Group Inc. | |
| 02.03.21 | Danone Neutral | JP Morgan Chase & Co. | |
| 02.03.21 | EssilorLuxottica Neutral | UBS AG | |
| 02.03.21 | Danone overweight | Barclays Capital | |
| 01.03.21 | Danone Sell | Société Générale Group S.A. (SG) | |
| 01.03.21 | Holcim buy | Kepler Cheuvreux | |
| 01.03.21 | Holcim Outperform | Credit Suisse Group | |
| 01.03.21 | Danone Neutral | JP Morgan Chase & Co. | |
| 01.03.21 | Carrefour overweight | JP Morgan Chase & Co. | |
| 01.03.21 | Kering buy | Jefferies & Company Inc. | |
| 26.02.21 | TotalEnergies market-perform | Bernstein Research | |
| 26.02.21 | Engie (ex GDF Suez) overweight | JP Morgan Chase & Co. | |
| 26.02.21 | SAFRAN Hold | Deutsche Bank AG | |
| 26.02.21 | Saint-Gobain buy | Deutsche Bank AG | |
| 26.02.21 | AXA buy | Deutsche Bank AG | |
| 26.02.21 | Unibail-Rodamco Neutral | UBS AG | |
| 26.02.21 | Saint-Gobain buy | UBS AG | |
| 26.02.21 | AXA Neutral | UBS AG | |
| 26.02.21 | Saint-Gobain Hold | Jefferies & Company Inc. | |
| 26.02.21 | Holcim Hold | Jefferies & Company Inc. | |
| 26.02.21 | SAFRAN buy | UBS AG | |
| 26.02.21 | Holcim overweight | Morgan Stanley | |
| 26.02.21 | Engie (ex GDF Suez) buy | Goldman Sachs Group Inc. | |
| 26.02.21 | Holcim overweight | JP Morgan Chase & Co. | |
| 26.02.21 | AXA buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.02.21 | AXA overweight | JP Morgan Chase & Co. | |
| 26.02.21 | Saint-Gobain overweight | JP Morgan Chase & Co. | |
| 26.02.21 | AXA Outperform | RBC Capital Markets | |
| 26.02.21 | SAFRAN Neutral | Credit Suisse Group | |
| 25.02.21 | AXA Neutral | UBS AG | |
| 25.02.21 | AXA overweight | JP Morgan Chase & Co. | |
| 25.02.21 | AXA overweight | Barclays Capital | |
| 25.02.21 | SAFRAN buy | Goldman Sachs Group Inc. | |
| 25.02.21 | SAFRAN Neutral | JP Morgan Chase & Co. | |
| 25.02.21 | AXA Outperform | RBC Capital Markets |